Literature DB >> 21991279

Self-experience in the early phases of schizophrenia: 5-year follow-up of the Copenhagen Prodromal Study.

Josef Parnas1, Andrea Raballo, Peter Handest, Lennart Jansson, Anne Vollmer-Larsen, Ditte Saebye.   

Abstract

Despite the avalanche of empirical data on prodromal/"at risk" conditions, the essential aspects of the vulnerability to the schizophrenia spectrum remain largely unaddressed. We report here the results of the Copenhagen Schizophrenia Prodromal Study, a prospective, observational study of first admission patients in putative state of beginning psychosis (N=151) with a follow-up length of 60 months. At follow-up, the rate of conversion to schizophrenia spectrum diagnosis was 37%, whereas the conversion rate from schizotypal disorder to schizophrenia was 25%. High levels of perplexity and self-disorders baseline scores yielded the best prediction of the subsequent development of schizophrenia spectrum disorders. Escalating transitions within the spectrum (i.e., from schizotypal disorder to schizophrenia) were not associated to any candidate psychopathological predictor.

Entities:  

Keywords:  Schizophrenia spectrum; anomalous subjective experiences; diagnostic stability; prodrome; psychosis; schizotypal disorder; vulnerability

Year:  2011        PMID: 21991279      PMCID: PMC3188774          DOI: 10.1002/j.2051-5545.2011.tb00057.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  33 in total

Review 1.  Genetics and psychopathology of spectrum phenotypes.

Authors:  J Parnas
Journal:  Acta Psychiatr Scand       Date:  2000-06       Impact factor: 6.392

2.  The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe.

Authors:  Joachim Klosterkötter; Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Don Linszen; Max Birchwood; Georg Juckel; Anthony Morrison; José Luis Vázquèz-Barquero; Martin Hambrecht; Heinrich VON Reventlow
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

3.  Use of ICD-10 diagnoses in Danish psychiatric hospital-based services in 2001-2007.

Authors:  Povl Munk-Jørgensen; Malene Najarraq Lund; Aksel Bertelsen
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

4.  Schizophrenic autism: clinical phenomenology and pathogenetic implications.

Authors:  Josef Parnas; Pierre Bovet; Dan Zahavi
Journal:  World Psychiatry       Date:  2002-10       Impact factor: 49.548

5.  Clinical characteristics of first-admitted patients with ICD-10 schizotypal disorder.

Authors:  Peter Handest; Josef Parnas
Journal:  Br J Psychiatry Suppl       Date:  2005-08

6.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

7.  Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark.

Authors:  S S Kety; P H Wender; B Jacobsen; L J Ingraham; L Jansson; B Faber; D K Kinney
Journal:  Arch Gen Psychiatry       Date:  1994-06

8.  Early intervention in psychosis: concepts, evidence and future directions.

Authors:  Patrick D McGorry; Eóin Killackey; Alison Yung
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

9.  Anomalies of subjective experience in schizophrenia and psychotic bipolar illness.

Authors:  J Parnas; P Handest; D Saebye; L Jansson
Journal:  Acta Psychiatr Scand       Date:  2003-08       Impact factor: 6.392

10.  Looking at the schizophrenia spectrum through the prism of self-disorders: an empirical study.

Authors:  Andrea Raballo; Ditte Sæbye; Josef Parnas
Journal:  Schizophr Bull       Date:  2009-06-15       Impact factor: 9.306

View more
  37 in total

1.  Clinical manifestations of self-disorders and the Gestalt of schizophrenia.

Authors:  Mads Gram Henriksen; Josef Parnas
Journal:  Schizophr Bull       Date:  2012-02-23       Impact factor: 9.306

2.  The self and schizophrenia: some open issues.

Authors:  Mario Maj
Journal:  World Psychiatry       Date:  2012-06       Impact factor: 49.548

3.  The core Gestalt of schizophrenia.

Authors:  Josef Parnas
Journal:  World Psychiatry       Date:  2012-06       Impact factor: 49.548

4.  The new impact factor of World Psychiatry.

Authors:  Gaia Sampogna
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

5.  WPA Scientific Sections.

Authors:  Afzal Javed
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

6.  Perplexity and meaning: toward a phenomenological "core" of psychotic experiences.

Authors:  Clara S Humpston
Journal:  Schizophr Bull       Date:  2013-05-22       Impact factor: 9.306

7.  A case of rapid conversion to psychosis of delusional misidentification associated with derealisation, verbal memory impairment and FDG-PET imaging abnormalities.

Authors:  Anna Comparelli; Georgios D Kotzalidis; Simone Di Pietro; Antonio Del Casale; Antonella De Carolis
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-05-08       Impact factor: 4.785

8.  Strange-face-in-the-mirror illusion and schizotypy during adolescence.

Authors:  Eduardo Fonseca-Pedrero; Deborah Badoud; Lia Antico; Giovanni B Caputo; Stephan Eliez; Sophie Schwartz; Martin Debbané
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

Review 9.  Neurobiological Models of Self-Disorders in Early Schizophrenia.

Authors:  A Mishara; I Bonoldi; P Allen; G Rutigliano; J Perez; P Fusar-Poli; P McGuire
Journal:  Schizophr Bull       Date:  2015-09-18       Impact factor: 9.306

10.  Schizotypal personality disorder in individuals with the Attenuated Psychosis Syndrome: Frequent co-occurrence without an increased risk for conversion to threshold psychosis.

Authors:  Anthony W Zoghbi; Joel A Bernanke; Julia Gleichman; Michael D Masucci; Cheryl M Corcoran; Allegra Califano; Justin Segovia; Tiziano Colibazzi; Michael B First; Gary Brucato; Ragy R Girgis
Journal:  J Psychiatr Res       Date:  2019-04-21       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.